{"id":10758,"date":"2024-05-26T17:47:18","date_gmt":"2024-05-26T17:47:18","guid":{"rendered":"https:\/\/euromorning.com\/valneva-aktie-geht-der-absturz-in-richtung-237-euro-weiter\/"},"modified":"2024-05-26T17:47:18","modified_gmt":"2024-05-26T17:47:18","slug":"valneva-aktie-geht-der-absturz-in-richtung-237-euro-weiter","status":"publish","type":"post","link":"https:\/\/euromorning.com\/nl\/valneva-aktie-geht-der-absturz-in-richtung-237-euro-weiter\/","title":{"rendered":"Valneva Aktie: Geht der Absturz in Richtung 2,37 Euro weiter?"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div id=\"\">&#13;<br \/>\n            &#13;<br \/>\n            &#13;<br \/>\n              <em>&#13;<\/p>\n<p class=\"autorenzeile half-top full-bottom\">05.03.2024 08:30 Uhr &#8211; Autor: <a href=\"https:\/\/www.4investors.de\/nachrichten\/autoren\/michael-barck.php\" class=\"contentLink\" title=\"Alle Informationen zum 4investors-Autoren Michael Barck\">Michael Barck<\/a>\u00a0\u00a0<a href=\"https:\/\/twitter.com\/michaelbarck2\" target=\"_blank\" rel=\"noopener\" title=\"Kontakt zu unserem Autor Michael Barck auf Twitter\">auf twitter<\/a>                <\/p>\n<p>&#13;<br \/>\n              <\/em>&#13;<br \/>\n              <amp-img class=\"full-bottom\" src=\"https:\/\/www.4investors.de\/bilder1200\/medienpool\/unternehmen\/valneva\/valneva-labor-2.jpg\" layout=\"responsive\" width=\"1200\" height=\"675\" alt=\"Arbeiten im Labor von Valneva. Bild und Copyright: Valneva.\"\/><figcaption>Arbeiten im Labor von Valneva. Bild und Copyright: Valneva.<\/figcaption>&#13;<br \/>\n              <!--\n\n<div class=\"half-top full-bottom\">\n\n<div class=\"mittig\"><a href=\"https:\/\/investoren.karlsberg.de\" target=\"_blank\" rel=\"noopener\" title=\"Neue Karlsberg Anleihe 2024-2029 - Investor Relations\"><amp-img src=\"https:\/\/www.4investors.de\/werbung\/karlsberg-anleihe-2024.gif\" width=\"300\" height=\"250\" alt=\"Anzeige Neue Karlsberg Anleihe 2024-2029\"><\/amp-img><\/a><\/div>\n\n<\/div>\n\n--&#13;\n              \n\n<p class=\"full-top\">&#13;\n              <span>&#13;\n                Bisher ist der Valneva Aktie kein Ausbruch aus dem Baissetrend gelungen. Der Biotech-Titel versucht sich allerdings an der 3-Euro-Marke an einem neuen Boden. Ob dies gelingt, ist allerdings auch nach drei aufeinander folgenden...<\/span><\/p>\n\n\n<br \/>[ad_2]\n<br \/><a href=\"https:\/\/www.4investors.de\/nachrichten\/amp\/boerse.php?sektion=stock&ID=175476\">Bronlink<\/a>\n<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#13; &#13; &#13; &#13; 05.03.2024 08:30 Uhr &#8211; Autor: Michael Barck\u00a0\u00a0auf twitter &#13; &#13; Arbeiten im Labor von Valneva. Bild und Copyright: Valneva.&#13;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[990],"tags":[],"class_list":["post-10758","post","type-post","status-publish","format-standard","hentry","category-euronext-nl"],"_links":{"self":[{"href":"https:\/\/euromorning.com\/nl\/wp-json\/wp\/v2\/posts\/10758","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/euromorning.com\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/euromorning.com\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/euromorning.com\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/euromorning.com\/nl\/wp-json\/wp\/v2\/comments?post=10758"}],"version-history":[{"count":0,"href":"https:\/\/euromorning.com\/nl\/wp-json\/wp\/v2\/posts\/10758\/revisions"}],"wp:attachment":[{"href":"https:\/\/euromorning.com\/nl\/wp-json\/wp\/v2\/media?parent=10758"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/euromorning.com\/nl\/wp-json\/wp\/v2\/categories?post=10758"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/euromorning.com\/nl\/wp-json\/wp\/v2\/tags?post=10758"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}